Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PDL BioPharma, Inc.

http://www.pdl.com

Latest From PDL BioPharma, Inc.

Advanced Therapies From Orchard & Kite Win EMA Thumbs Up

Novartis’s siRNA for lowering cholesterol was also among the 10 new medicines that the European Medicines Agency this week said should be approved in the EU.

Europe Approvals

Kite’s Tecartus PRIMEd For EU Market With CHMP Nod

Gilead/Kite’s second CAR-T product is given the go-ahead for approval by the CHMP for mantle cell lymphoma.

Approvals Companies

EMA: Moment Of Truth For Two Curative Therapies & A Possible Cholesterol-Lowering Blockbuster

The sponsors of 11 new treatments should learn this week whether the European Medicines Agency will recommend EU marketing approval for their products.

Europe Approvals

COVID-19 Contracting Accelerated As US Fiscal Year 2020 Drew To A Close

US government stockpiles more drugs, refines pandemic surveillance with wastewater sampling and more as it braces for winter.

Coronavirus COVID-19 Distribution
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Eos Biotechnology, Inc.
    • LENSAR, Inc.
    • Noden Pharma DAC
    • Noden USA
    • Protein Design Labs, Inc.
UsernamePublicRestriction

Register